Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · C41E285702250302229
Magnesium Glycinate Bisglycinate + Vitamine B 6 Haute dose 1422 mg, 180 Gélules Origine Angleterre UK
midtail
3P
MEDICAMENTS
Last 4 weeks demand
9
▼ 80.9% vs prev 4w
Offer Stock
2
Σ Stock across 2 live offers (1P + 3P) · 2026-08-05
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-08-05 snapshot
Unit price
MAD 290
avg of last 30 sells · latest 2026-08-02
C41E285702250302229
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-08-03 · Total forecast: 145 units.
Actual
Realistic forecast
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate Bisglycinate + Vitamine B 6 Haute dose 1422 mg, 180 Gélules Origine Angleterre UK · in the midtail cohort · last 4 weeks 9 units, trending down -80.9% · on-hand 3 units
Signals the model saw
- Cohort: midtail (147 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.85 — moderate
- Recent trend: last 4w = 9 units · prev 4w = 47 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 4.5 units |
| Realistic forecast — next 4 weeks | 19.2 units |
| Realistic forecast — next 3 months | 73.4 units |
| Optimistic — next week | 7.7 units |
| Optimistic — next 4 weeks (reorder target) | 34.5 units |
| Optimistic — next 3 months (quarterly PO target) | 144.8 units |
| Legacy μ/wk (reorder pipeline) | 3.5 |
| Revenue exposure — optimistic, 3 months | MAD 41.9K |